Skip to main content
GUTS
NASDAQ Industrial Applications And Services

Fractyl Health Reports Q1 Results, Discloses Going Concern Warning, and Terminates ATM Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.77
Mkt Cap
$116.448M
52W Low
$0.377
52W High
$3.03
52W Position info
104% above low
Off High info
75% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GUTS has more than doubled off its 52-week low of $0.377.

Summary

Fractyl Health issued a 'going concern' warning and terminated its ATM offering, despite reporting a Q1 net income largely due to a non-cash gain, underscoring severe financial challenges and Nasdaq delisting risk.


Key Events · Earnings and Guidance · GUTS

  • Going Concern Warning Issued

    Management concluded that substantial doubt exists about the company's ability to continue as a going concern within twelve months from the report's issuance date, despite projecting cash runway into early 2027.

  • ATM Offering Terminated

    The $100 million at-the-market (ATM) equity offering program with Jefferies LLC was terminated effective April 6, 2026, removing a significant potential source of capital. Only $6.8 million in net proceeds were raised during its term.

  • Net Income Driven by Non-Cash Gain

    Q1 2026 reported a net income of $9.2 million, a significant swing from a $23.7 million loss in Q1 2025. However, this was primarily due to a $30.1 million non-cash gain from the change in fair value of warrant liabilities, masking an underlying operational loss.

  • Cash Position and Burn Rate

    Cash and cash equivalents decreased to $63.2 million as of March 31, 2026, from $81.5 million at year-end 2025. Net cash used in operating activities was $22.5 million for the quarter.


Analysis · GUTS · Industrial Applications And Services

This quarterly report reveals significant financial distress for Fractyl Health. The explicit 'going concern' warning indicates substantial doubt about the company's ability to continue operations for the next 12 months. This is compounded by the termination of its $100 million at-the-market (ATM) equity offering, removing a critical source of potential capital. While the company reported a net income, it was primarily driven by a large non-cash gain from warrant revaluation, masking continued operational losses and a significant cash burn. The ongoing Nasdaq delisting risk further highlights the precarious financial position.

At the time of this filing, GUTS was trading at $0.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $116.4M. The 52-week trading range was $0.38 to $3.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GUTS - Latest Insights

GUTS
Jul 15, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8001
Real-time Price: $0.6899 info
Change: -$0.1102 (-14%) info
Market Cap: $107.088M info
GUTS
Jul 15, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.8351
Real-time Price: $0.6899 info
Change: -$0.1452 (-17%) info
Market Cap: $107.088M info
GUTS
Jun 04, 2026, 7:08 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.790
Real-time Price: $0.6899 info
Change: -$0.1001 (-13%) info
Market Cap: $107.088M info
GUTS
Jun 04, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8079
Real-time Price: $0.6899 info
Change: -$0.118 (-15%) info
Market Cap: $107.088M info
GUTS
May 12, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.76995
Real-time Price: $0.6899 info
Change: -$0.08005 (-10%) info
Market Cap: $107.088M info